Form C-AR — Berkshire Biomedical Corp
0002048576-26-000002 · filed Mar 31, 2026
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 2048576
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 5950 BERKSHIRE LN., SUITE 375
DALLAS, TX 75225 - Phone
- —
Most recent fiscal year financials
- Total assets
- $212,889
- Cash
- —
- Short-term debt
- —
- Long-term debt
- $1,000,000
- Revenues
- $197,454
- COGS
- —
- Taxes paid
- —
- Net income
- $59,066
Likely investment adviser (not guaranteed)
-
BERKSHIRE CAPITAL HOLDINGS INC
medium CRD 801-53149
-
BERKSHIRE PARTNERS LLC
medium CRD 801-73336
View the original filing on SEC EDGAR ↗